|
|
 |
|
Viewing report
|
|
|
|
Celgene Corporation
Wright Investors' Service, May 2009, Pages: 42
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Celgene Corporation. There is a textual review of the financial results of Celgene Corporation versus NBTY Inc., Cephalon, Inc. and Watson Pharmaceuticals, Inc.. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Celgene Corporation are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Celgene Corporationincludes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Premium Company Profile Celgene
Celgene Corporation - Financial and Strategic Analysis Review
Analysis of Celgene Corporation
Celgene Corporation - SWOT Analysis
Celgene Corporation: PharmaVitae Profile
Wright Express Corporation
Curtiss-Wright Corporation
Celgene Corporation: PharmaVitae Model
Liquidity Services, Inc.
Smart Balance, Inc.,
Wright Medical Group, Inc.
International Financial Statement Analysis
|
|
|
|
